MedPath

Conventional Versus Left Bundle Branch Pacing in TAVI

Not Applicable
Not yet recruiting
Conditions
Heart Failure
Aortic Valve Stenosis
Pacemaker-Induced Cardiomyopathy
Transcatheter Aortic Valve Implantation
Interventions
Device: Left bundle branch pacemaker
Device: Conventional pacing
Registration Number
NCT05895097
Lead Sponsor
University Medical Centre Ljubljana
Brief Summary

This randomized study compares the effects of conventional (right ventricular pacing in patients with LVEF ≥ 40% and cardiac resynchronization therapy in patients with LVEF \< 40 %) versus left bundle branch pacing on left ventricular remodelling in patients with reduced left ventricular ejection fraction (\< 50 %) that need permanent pacemaker implantation after transcatheter aortic valve implantation (TAVI).

Detailed Description

Bradycardic heart rhythm disturbances are a common complication of TAVI. Patients who will develop the indication for permanent pacemaker implantation after TAVI will be randomly assigned to either the experimental (left bundle branch pacing) or conventional (right ventricular pacing in patients with LVEF ≥ 40% and cardiac resynchronization therapy in patients with LVEF \< 40 %) group. The investigators will compare the left ventricular ejection fraction (primary outcome) 12 months after randomization. The investigators will also compare electrocardiographic (QRS duration), clinical (NYHA status, 6-minute walking test, handgrip test, Kansas City Cardiomyopathy Questionnaire) and laboratory (proBNP) parameters 6 and 12 months, and other echocardiographic (left ventricular systolic and diastolic diameter, signs of dyssynchrony, myocardial work) parameters 12 months after pacemaker implantation in both groups.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Indication for permanent pacemaker implantation after transcatheter aortic valve implantation (during the same hospitalization)
  • Left ventricular ejection fraction < 50 %.
Exclusion Criteria
  • Unsuccessful TAVI procedure with life expectancy < 1 year
  • Ischemic cardiomyopathy with interventricular septal fibrosis (at least echocardiographic signs of fibrosis)
  • Severe kidney failure (glomerular filtration rate < 30 ml/min)
  • Previous permanent pacemaker

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LBB pacingLeft bundle branch pacemaker-
Conventional pacingConventional pacing-
Primary Outcome Measures
NameTimeMethod
Left ventricular ejection fraction12 months
Secondary Outcome Measures
NameTimeMethod
Left ventricular systolic diameter12 months
NT-proBNP concentration6 and 12 months
NYHA status6 and 12 months
6-minute walking test6 and 12 months
Hand grip test6 and 12 months
QRS durationbaseline, 6, and 12 months
Left ventricular diastolic diameter12 months
Global constructive work12 months

Positive work performed in systole + negative work performed in isovolumetric relaxation

Global work index12 months

Amount of myocardial work performed by the left ventricle during systole.

Global wasted work12 months

Negative work performed in systole + positive work performed in isovolumetric relaxation

Global work efficiency12 months

Percentage of constructive work over total work = Constructive work/(constructive work + wasted work)

Signs of mechanical dyssynchrony12 months

Presence of at least one of the echocardiographic signs of mechanical dyssynchrony, such as apical rocking and septal flash.

Systolic pulmonary artery pressure (echocardiographic parameter)12 months
The Kansas City Cardiomyopathy Questionnaire (KCCQ-12)6 and 12 months

KCCQ scores are scaled from 0 to 100 and frequently summarized in 25-point ranges, where scores represent health status as follows: 0 to 24: very poor to poor; 25 to 49: poor to fair; 50 to 74: fair to good; and 75 to 100: good to excellent.

Trial Locations

Locations (1)

University Medical Centre Ljubljana

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath